Clincosm LogoSign in Get a demo

Retrospective Analysis of PET Brain Imaging in Chronic Cancer Pain

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04537845
Collaborator
(none)
119
Enrollment
1
Location
21
Anticipated Duration (Months)
5.7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Cancer pain deteriorated in quality of life and related with numerous psychosocial problems. Over the one third of cancer patient suffered from moderate to severe cancer pain, even under adequate pain management.

The 18F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) images can provide quantitative results in clinical oncology. As a functional neuroimaging, the PET evidently provided anatomical activated regions, size, and spatial extent information. In this retrospective study, we use FDG-PET to investigate changes concerning the glucose metabolism in the brain with or without cancer pain.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    119 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    FDG PET Imaging Study of Brain Metabolic Change in Chronic Cancer Pain Patient: a Retrospective Analysis
    Actual Study Start Date :
    Mar 2, 2020
    Actual Primary Completion Date :
    Aug 8, 2020
    Anticipated Study Completion Date :
    Dec 1, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    with cancer pain
    without cancer pain

    Outcome Measures

    Primary Outcome Measures

    1. Find the location of brain metabolic changes, pain scale [12 months]

      This retrospective analysis only compare image and clinical record including pain scale

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • cancer patient
    Exclusion Criteria:
    • no brain metastasis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Taiwan University Hosipital Taipei City Taiwan 100

    Sponsors and Collaborators

    • National Taiwan University Hospital

    Investigators

    • Principal Investigator: Wen-ying Lin, National Taiwan University Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    National Taiwan University Hospital
    ClinicalTrials.gov Identifier:
    NCT04537845
    Other Study ID Numbers:
    • 201907175RINA
    First Posted:
    Sep 3, 2020
    Last Update Posted:
    Sep 13, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Cancer Pain

    Study Results

    No Results Posted as of Sep 13, 2021